Steffen Schmitz-Valckenberg

5PUBLICATIONS
5CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)HaematologyAboriginal and Torres Strait Islander knowledge management methodsGene and molecular therapyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 30, 2024
Age-related macular degeneration: natural history revisited in geographic atrophy.

Eliza Broadbent, Sandrine H Künzel, Maximilian Pfau

|Jan 10, 2024
Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression.

M A Zouache, B T Richards, C M Pappas

|Aug 30, 2023
The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients.

Patty P A Dhooge, Philipp T Möller, Camiel J F Boon

|Feb 21, 2022
A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration-the FALCON study.

F G Holz, Steffen Schmitz-Valckenberg, A Wolf

|Oct 07, 2021
Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis.

Sarah Rieck, Sofia Kilgus, Johanna H Meyer

Pageof 1

Frequent Collaborators

1 joint publications

M A Zouache

1 joint publications

Lan Zhao

1 joint publications

Bernd K Fleischmann

1 joint publications

Daniela Wenzel